ASCO: practice changing studies in gastrointestinal cancer

Por Prager, Gerald
Publicado no ESMO Open (2017)

Towards shedding some light on regorafenib treatment in refractory metastatic colorectal cancer

Por Prager, Gerald, Argilés, Guillem
Publicado no ESMO Open (2017)

Personalized Adjuvant Treatment of Colon Cancer

Por Taghizadeh, Hossein, Prager, Gerald W
Publicado no Visc Med (2020)

Molecular pathology of cancer: how to communicate with disease

Por Birner, Peter, Prager, Gerald, Streubel, Berthold
Publicado no ESMO Open (2016)

Integrins in the Spotlight of Cancer

Por Bianconi, Daniela, Unseld, Matthias, Prager, Gerald W.
Publicado no Int J Mol Sci (2016)

Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer

Por Kieler, Markus, Unseld, Matthias, Bianconi, Daniela, Prager, Gerald W.
Publicado no Memo (2017)

Angiogenesis in cancer: Anti-VEGF escape mechanisms

Por Prager, Gerald W., Poettler, Marina, Unseld, Matthias, Zielinski, Christoph C.
Publicado no Transl Lung Cancer Res (2012)

New Treatment Options for Advanced Gastroesophageal Tumours: Mature for the Current Practice?

Por Puhr, Hannah Christina, Preusser, Matthias, Prager, Gerald, Ilhan-Mutlu, Aysegül
Publicado no Cancers (Basel) (2020)

A real-world analysis of second-line treatment options in pancreatic cancer: liposomal-irinotecan plus 5-fluorouracil and folinic acid

Por Kieler, Markus, Unseld, Matthias, Bianconi, Daniela, Scheithauer, Werner, Prager, Gerald W.
Publicado no Ther Adv Med Oncol (2019)

Maximising clinical benefit with adequate patient management beyond the second line in mCRC

Por Argiles, Guillem, Arnold, Dirk, Prager, Gerald, Sobrero, Alberto F, Van Cutsem, Eric
Publicado no ESMO Open (2019)

Applied precision medicine in metastatic pancreatic ductal adenocarcinoma

Por Taghizadeh, Hossein, Müllauer, Leonhard, Mader, Robert M., Schindl, Martin, Prager, Gerald W.
Publicado no Ther Adv Med Oncol (2020)

Molecularly guided treatment of metastatic parotid gland carcinoma in adults

Por Taghizadeh, Hossein, Müllauer, Leonhard, Mader, Robert M., Füreder, Thorsten, Prager, Gerald W.
Publicado no Wien Klin Wochenschr (2020)

CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior

Por Poettler, Marina, Unseld, Matthias, Braemswig, Kira, Haitel, Andrea, Zielinski, Christoph C, Prager, Gerald W
Publicado em 2013

Haemostatic biomarkers for prognosis and prediction of therapy response in patients with metastatic colorectal cancer

Por Moik, Florian, Posch, Florian, Grilz, Ella, Scheithauer, Werner, Pabinger, Ingrid, Prager, Gerald, Ay, Cihan
Publicado no Thromb Res (2020)

Case report: impressive response to pembrolizumab in a patient with mismatch-repair deficient metastasized colorectal cancer and bulky disease

Por Kieler, Markus, Scheithauer, Werner, Zielinski, Christoph C, Chott, Andreas, Al-Mukhtar, Ali, Prager, Gerald W
Publicado no ESMO Open (2016)

Plasma levels of interleukin-33 and soluble suppression of tumorigenicity 2 in patients with advanced pancreatic ductal adenocarcinoma undergoing systemic chemotherapy

Por Kieler, Markus, Unseld, Matthias, Wojta, Johann, Kaider, Alexandra, Bianconi, Daniela, Demyanets, Svitlana, Prager, Gerald W.
Publicado no Med Oncol (2018)

First evidence for the antitumor activity of nanoliposomal irinotecan with 5-fluorouracil and folinic acid in metastatic biliary tract cancer

Por Taghizadeh, Hossein, Unseld, Matthias, Schmiderer, Andreas, Djanani, Angela, Wilthoner, Klaus, Buchinger, Dieter, Prager, Gerald W.
Publicado no Cancer Chemother Pharmacol (2020)

Outcome of Targeted Therapy Recommendations for Metastatic and Recurrent Head and Neck Cancers

Por Taghizadeh, Hossein, Mader, Robert M., Müllauer, Leonhard, Fuereder, Thorsten, Kautzky-Willer, Alexandra, Prager, Gerald W.
Publicado no Cancers (Basel) (2020)

Precision Medicine for the Management of Therapy Refractory Colorectal Cancer

Por Taghizadeh, Hossein, Mader, Robert M., Müllauer, Leonhard, Erhart, Friedrich, Kautzky-Willer, Alexandra, Prager, Gerald W.
Publicado no J Pers Med (2020)

Impact of New Chemotherapy Regimens on the Treatment Landscape and Survival of Locally Advanced and Metastatic Pancreatic Cancer Patients

Por Kieler, Markus, Unseld, Matthias, Bianconi, Daniela, Schindl, Martin, Kornek, Gabriela V., Scheithauer, Werner, Prager, Gerald W.
Publicado no J Clin Med (2020)